Sector consensus Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.090 USD | -3.27% |
|
-7.08% | -48.29% |
| Nov. 26 | Sector Update: Health Care Stocks Edge Higher Premarket Wednesday | MT |
| Nov. 25 | Myriad Genetics Collaborates With Clairity, MagView to Roll Out AI Platform for Breast Cancer Risk Assessment | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | $8.52 | +16.23% | 10 | ||||||
| €123.46 | +18.49% | 14 | ||||||
| $100.82 | -7.1% | 22 | ||||||
| $38.33 | +35.36% | 9 | ||||||
| CN¥69.64 | +16.43% | 11 | ||||||
| $80.93 | +30.8% | 14 | ||||||
| €92.5 | +53.96% | 12 | ||||||
| CN¥44.48 | +23.84% | 4 | ||||||
| $16.57 | -8.7% | 14 | ||||||
| SEK 193.5 | +39.01% | 4 | ||||||
| CN¥25.95 | +30.21% | 2 | ||||||
| CN¥26.09 | +25.92% | 3 | ||||||
| - | - | CN¥20 | +34.86% | 1 | ||||
| CN¥28.33 | +30.11% | 4 | ||||||
| $37.25 | -5.98% | 8 | ||||||
| - | - | - | - | - | ||||
| Average | 60.42 | +22.23% | 9 | ||||||
| Weighted average by Cap. | 82.01 | +18.63% | 13 |
- Stock Market
- Equities
- MYGN Stock
- Sector Myriad Genetics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
